Abstract
摘要
相似文献
1
[Newly developed muscle relaxants].[新研发的肌肉松弛剂]
Masui. 1997 Nov;46 Suppl:S200-4.
2
Neuromuscular blocking agents.
Vet Clin North Am Small Anim Pract. 1992 Mar;22(2):341-7. doi: 10.1016/s0195-5616(92)50629-5.
3
Clinical pharmacology of the neuromuscular blocking agents.神经肌肉阻滞剂的临床药理学
DICP. 1991 Jan;25(1):54-64. doi: 10.1177/106002809102500111.
4
Recent advances in myorelaxant therapy.肌松治疗的最新进展。
Paediatr Anaesth. 2001;11(5):523-31. doi: 10.1046/j.1460-9592.2001.00661.x.
5
Muscle relaxants in paediatric day case surgery.小儿日间手术中的肌肉松弛剂
Eur J Anaesthesiol Suppl. 2001;23:47-52.
6
Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.顺式阿曲库铵与米库氯铵、阿曲库铵、维库溴铵或罗库溴铵联合使用时的神经肌肉相互作用。
Anaesthesia. 1998 Sep;53(9):872-8. doi: 10.1046/j.1365-2044.1998.00492.x.
7
Update on newer neuromuscular blocking drugs.
Ann Acad Med Singap. 1994 Nov;23(6 Suppl):108-13.
8
Pharmacodynamics of vecuronium, atracurium, tubocurarine and their combinations in the rat in vivo.
Eur J Anaesthesiol. 1985 Sep;2(3):279-84.
9
The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
J Med Assoc Ga. 1994 Aug;83(8):473-6, 484.
10
Atracurium and vecuronium: two unique neuromuscular blocking agents.
Drug Intell Clin Pharm. 1984 Sep;18(9):714-6. doi: 10.1177/106002808401800907.
Zotero 插件